• Cancer Drug Promising for Alzheimer's Disease

    9 days ago - By Medscape

    In a small phase 2 trial, GM-CSF/sargramostim provided measurable disease-modifying and memory-enhancing benefits in patients with mild-to-moderate Alzheimer's disease.
    Medscape Medical News
    Read more ...